This compound is a boronic ester pharmaceutical intermediate featuring a fluorinated aromatic ring and a methoxy substituent. It is primarily used in research and manufacturing settings as a building block for the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1165936-00-4
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Boronic ester pharmaceutical intermediate
8-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,4-DIOXASPIRO[4.5]DEC-7-ENE
Boronic ester pharmaceutical intermediate
(3S)-2,3,4,9-tetrahydro-1H-carbazol-3-amine
Pharmaceutical intermediate
N-Boc-(2S,3S)-3-amino-2-hydroxy-4-phenyl-butyric acid
Boc-protected amino acid intermediate
Methyl (3E)-2,3-dihydro-3-(methoxyphenylmethylene)-2-oxo-1H-indole-6-carboxylate
pharmaceutical intermediate
Rac Duloxetine 3-Thiophene IsoMer Oxalate
pharmaceutical intermediate impurity standard
2-(2-fluoro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MALXDJBHSGDLGF-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=C(C(=CC=C2)OC)F
—